Literature DB >> 1291596

Effect of naltrexone treatment on the treadmill exercise-induced hormone release in amenorrheic women.

G Botticelli1, A Bacchi Modena, D Bresciani, P Villa, L Aguzzoli, P Florio, R E Nappi, F Petraglia, A R Genazzani.   

Abstract

The effect of an acute physical stress on hormone secretions before and after a 10-day naltrexone treatment in untrained healthy and amenorrheic women was investigated. Plasma levels of pituitary (LH, FSH, prolactin, GH, ACTH, beta-endorphin) and adrenal (cortisol, androstenedione, testosterone) hormones were measured at rest and in response to 60 min of physical exercise. The test was done both before and after a 10-day naltrexone (50 mg/day) treatment. Graded levels of treadmill exercise (50, 70 and 90% of maximal oxygen uptake (VO2) every 20 min) was used as physical stressor. While mean +/- SE plasma LH levels in control women were higher than in amenorrheic patients and increased following the naltrexone treatment (p < 0.01), no significant differences of basal plasma hormonal levels were observed between amenorrheic and eumenorrheic women, both before and after naltrexone treatment. Physical exercise at 90% VO2 induced a significant increase in plasma GH, ACTH, beta-endorphin, cortisol, androstenedione and testosterone levels in controls before naltrexone treatment (p < 0.01). The mean increase in plasma androstenedione and testosterone levels in control women was significantly higher after naltrexone treatment (p < 0.01). In amenorrheic patients before naltrexone, physical exercise induced an increase in plasma prolactin and GH levels, but not in plasma ACTH, beta-endorphin, cortisol, testosterone and androstenedione. After naltrexone treatment, the exercise induced a significant plasma ACTH, beta-endorphin and cortisol levels, while the increase of plasma prolactin levels was significantly higher than before treatment (p < 0.01).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1291596     DOI: 10.1007/bf03348817

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  35 in total

1.  Secondary amenorrhoea in athletes.

Authors:  C B Feicht; T S Johnson; B J Martin; K E Sparkes; W W Wagner
Journal:  Lancet       Date:  1978-11-25       Impact factor: 79.321

Review 2.  The hypothalamic control of the menstrual cycle and the role of endogenous opioid peptides.

Authors:  M Ferin; D Van Vugt; S Wardlaw
Journal:  Recent Prog Horm Res       Date:  1984

3.  Evidence for increased dopaminergic and opioid activity in patients with hypothalamic hypogonadotropic amenorrhea.

Authors:  M E Quigley; K L Sheehan; R F Casper; S S Yen
Journal:  J Clin Endocrinol Metab       Date:  1980-05       Impact factor: 5.958

4.  Abnormal cortisol secretion and responses to corticotropin-releasing hormone in women with hypothalamic amenorrhea.

Authors:  B M Biller; H J Federoff; J I Koenig; A Klibanski
Journal:  J Clin Endocrinol Metab       Date:  1990-02       Impact factor: 5.958

5.  Failure of naloxone to influence plasma growth hormone, prolactin, and cortisol secretions induced by insulin hypoglycemia.

Authors:  I Wakabayashi; R Demura; N Miki; E Ohmura; H Miyoshi; K Shizume
Journal:  J Clin Endocrinol Metab       Date:  1980-03       Impact factor: 5.958

6.  Endorphins and the regulations of the human menstrual cycle.

Authors:  J Blankstein; F I Reyes; J S Winter; C Faiman
Journal:  Clin Endocrinol (Oxf)       Date:  1981-03       Impact factor: 3.478

7.  Proopiocortin-related peptide plasma levels throughout prepuberty and puberty.

Authors:  A R Genazzani; F Facchinetti; C Pintor; R Puggioni; D Parrini; F Petraglia; F Bagnoli; R Corda
Journal:  J Clin Endocrinol Metab       Date:  1983-07       Impact factor: 5.958

8.  Opioids act centrally to modulate stress-induced decrease in luteinizing hormone in the rat.

Authors:  F Petraglia; W Vale; C Rivier
Journal:  Endocrinology       Date:  1986-12       Impact factor: 4.736

9.  Naloxone-induced prolactin secretion in women: evidence against a direct prolactin stimulatory effect of endogenous opioids.

Authors:  N S Cetel; M E Quigley; S S Yen
Journal:  J Clin Endocrinol Metab       Date:  1985-01       Impact factor: 5.958

10.  The effects of exercise on pubertal progression and reproductive function in girls.

Authors:  M P Warren
Journal:  J Clin Endocrinol Metab       Date:  1980-11       Impact factor: 5.958

View more
  1 in total

Review 1.  Effect of Exercise on Ovulation: A Systematic Review.

Authors:  Osnat Hakimi; Luiz-Claudio Cameron
Journal:  Sports Med       Date:  2017-08       Impact factor: 11.136

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.